Just wonder if anyone participates in Window 2 clinical trial of MD Anderson where patients receive Ibrutinib in the first 4 months, combine with Rituximab and add Venetoclax in month 5. Chemo will be followed if in the medium and high risk. Then another 2-3 years in maintenance with Ibrutiniv, Venetoclax and Rituximab.
Any idea or advice, please whether to join this trial? How is it compared with chemo + transplant.
One of the thing if you join trial, you have to have CT scan every month, ehich is harmful as well?
Treatment 
Non Hodgkin's lymphoma 
The Report : Stage 4, Cell B, Follicular, Non Hodgkin's Lymphoma, 5-16-18